| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |